Dark

LGND
Ligand Pharmaceuticals Inc.
stock NASDAQ

At Close

Dec 23, 2025 3:59:56 PM EST

197.29USD-0.338%(-0.67)114,643

0.00Bid 0.00Ask 0.00Spread

Pre-market

Dec 23, 2025 9:15:30 AM EST

198.40USD+0.222%(+0.44)2,633

After-hours

Dec 23, 2025 4:00:30 PM EST

197.39USD+0.051%(+0.10)611

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

3.90B

CEO

John Higgins

Headquarters

San Diego, California, USA

Industry

Biotechnology

Next Earnings

Mar 4, 2026 (70d)

Last Dividend

Apr 3, 20072.500

Last Split

Nov 19, 20101for5.9999reverse

AMGN SPPI GSK BAX BMY JNJ LLY PFE MRK GTXI XLV

LGND Stats

Avg. Vol. 10 Day

189,987

Avg. Vol. 30 Day

215,187

Employees

Market Cap

3,895,799,657

Shares Out.

19,681,720

On/Off Exchange

58%/42%

6 Month Beta

0.90

1 Year Beta

0.86

2 Year Beta

0.99

3 Year Beta

0.96

52 Week Low

93.58

52 Week High

212.49

SMA50

193.64

SMA200

145.01

1 Week

+2.94%

1 Month

-4.33%

3 Month

+15.99%

6 Month

+72.16%

1 Year

+73.94%

2 Year

+176.80%

5 Year

+87.32%

Profile

ligand, a pharmaceutical company, is assembling a large and diverse portfolio of current and near-term commercial revenue generating assets to assist the long-term financial growth of the company. we operate this business on a lean cost structure that allows us to maximize cash flow and ultimately deliver a meaningful return for our shareholders.

LGND Stock Summary

Ligand Pharmaceuticals Inc. (NASDAQ:LGND) stock price today is $197.29, and today's volume is 114,643. LGND is down -0.338% today. The 30 day average volume is 215,187. LGND market cap is 3.90B with 19,681,720 shares outstanding.